A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.
News|Articles|October 27, 2025
Sarah McLeod, PhD, breaks down high cure rates with zoliflodacin for uncomplicated gonorrhea
Author(s)Joshua Fitch, Senior Editor , Sarah McLeod, PhD
Fact checked by: Joshua Fitch, Senior Editor
Zoliflodacin study investigator Sarah McLeod, PhD, highlights data presented at IDWeek 2025 in this Q&A with Contemporary Pediatrics.
Advertisement
Advertisement
New subgroup analyses from the global phase 3 zoliflodacin trial highlight the drug’s efficacy against multidrug-resistant Neisseria gonorrhoeae, including ciprofloxacin-resistant strains, across all infection sites and patient subgroups. The data were presented at
Related to this article
A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
Hai D. Nguyen-Tran, MD, discusses clinical signs, neurologic warning symptoms, supportive care, and preventing the spread of hand, foot, and mouth disease.
Diana F. Clarke, PharmD, explains how IMPAACT 2023 supported dolutegravir from birth, plus dosing tips and open questions for preterm infants.
An updated AAP policy statement renews the call to ban raw milk sales, citing pathogen risks to children and pregnant people and an emerging H5N1 concern.
At AAP 2026, Rana Hamdy, MD, discussed when to test children for group A strep, antibiotic selection, and strategies to improve prescribing.
Nikta Forghani, MD, explains when irregular menstrual cycles warrant evaluation and how pediatricians can identify PCOS and relative energy deficiency.
Advertisement
Advertisement